 | • レポートコード：D005-00783 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、変形性関節症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症治療の種類別市場規模（薬物、補助器具）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、GlaxoSmithKline、Johnson & Johnson、Abbott、Novartis、Stryker、Zimmer Biomet ・地域別グローバル市場分析 2015年-2020年 ・変形性関節症治療の北米市場（アメリカ、カナダ、メキシコ） ・変形性関節症治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・変形性関節症治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・変形性関節症治療の南米市場（ブラジル、アルゼンチン） ・変形性関節症治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：薬物、補助器具 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Osteoarthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Osteoarthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Osteoarthritis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Osteoarthritis Treatment market has been segmented into:
Drugs
Assistive Devices
By Application, Osteoarthritis Treatment has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Osteoarthritis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Osteoarthritis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Osteoarthritis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Osteoarthritis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Osteoarthritis Treatment Market Share Analysis
Osteoarthritis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Osteoarthritis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Osteoarthritis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Osteoarthritis Treatment are:
Pfizer
GlaxoSmithKline
Johnson & Johnson
Abbott
Novartis
Stryker
Zimmer Biomet
Table of Contents
1 Osteoarthritis Treatment Market Overview
1.1 Product Overview and Scope of Osteoarthritis Treatment
1.2 Classification of Osteoarthritis Treatment by Type
1.2.1 Global Osteoarthritis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Osteoarthritis Treatment Revenue Market Share by Type in 2019
1.2.3 Drugs
1.2.4 Assistive Devices
1.3 Global Osteoarthritis Treatment Market by Application
1.3.1 Overview: Global Osteoarthritis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Osteoarthritis Treatment Market by Regions
1.4.1 Global Osteoarthritis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Osteoarthritis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Osteoarthritis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Osteoarthritis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Osteoarthritis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Osteoarthritis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Osteoarthritis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Stryker
2.6.1 Stryker Details
2.6.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Stryker SWOT Analysis
2.6.4 Stryker Product and Services
2.6.5 Stryker Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zimmer Biomet
2.7.1 Zimmer Biomet Details
2.7.2 Zimmer Biomet Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zimmer Biomet SWOT Analysis
2.7.4 Zimmer Biomet Product and Services
2.7.5 Zimmer Biomet Osteoarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Osteoarthritis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Osteoarthritis Treatment Players Market Share
3.2.2 Top 10 Osteoarthritis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Osteoarthritis Treatment Revenue and Market Share by Regions
4.2 North America Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
5 North America Osteoarthritis Treatment Revenue by Countries
5.1 North America Osteoarthritis Treatment Revenue by Countries (2015-2020)
5.2 USA Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Osteoarthritis Treatment Revenue by Countries
6.1 Europe Osteoarthritis Treatment Revenue by Countries (2015-2020)
6.2 Germany Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Osteoarthritis Treatment Revenue by Countries
7.1 Asia-Pacific Osteoarthritis Treatment Revenue by Countries (2015-2020)
7.2 China Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
8 South America Osteoarthritis Treatment Revenue by Countries
8.1 South America Osteoarthritis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Osteoarthritis Treatment by Countries
9.1 Middle East & Africa Osteoarthritis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Osteoarthritis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Osteoarthritis Treatment Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2015-2025)
10.4 Assistive Devices Revenue Growth Rate (2015-2025)
11 Global Osteoarthritis Treatment Market Segment by Application
11.1 Global Osteoarthritis Treatment Revenue Market Share by Application (2015-2020)
11.2 Osteoarthritis Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Osteoarthritis Treatment Market Size Forecast (2021-2025)
12.1 Global Osteoarthritis Treatment Market Size Forecast (2021-2025)
12.2 Global Osteoarthritis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Osteoarthritis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Osteoarthritis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Osteoarthritis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Osteoarthritis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Osteoarthritis Treatment Major Business
Table 7. Pfizer Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Osteoarthritis Treatment Product and Solutions
Table 10. Pfizer Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Osteoarthritis Treatment Major Business
Table 13. GlaxoSmithKline Osteoarthritis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Osteoarthritis Treatment Product and Solutions
Table 16. GlaxoSmithKline Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Osteoarthritis Treatment Major Business
Table 19. Johnson & Johnson Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Osteoarthritis Treatment Product and Solutions
Table 22. Johnson & Johnson Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott Osteoarthritis Treatment Major Business
Table 25. Abbott Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott Osteoarthritis Treatment Product and Solutions
Table 28. Abbott Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Osteoarthritis Treatment Major Business
Table 31. Novartis Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Osteoarthritis Treatment Product and Solutions
Table 34. Novartis Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Stryker Corporate Information, Location and Competitors
Table 36. Stryker Osteoarthritis Treatment Major Business
Table 37. Stryker Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Stryker SWOT Analysis
Table 39. Stryker Osteoarthritis Treatment Product and Solutions
Table 40. Stryker Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zimmer Biomet Corporate Information, Location and Competitors
Table 42. Zimmer Biomet Osteoarthritis Treatment Major Business
Table 43. Zimmer Biomet Osteoarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Zimmer Biomet SWOT Analysis
Table 45. Zimmer Biomet Osteoarthritis Treatment Product and Solutions
Table 46. Zimmer Biomet Osteoarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Osteoarthritis Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Osteoarthritis Treatment Revenue Share by Players (2015-2020)
Table 49. Global Osteoarthritis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Osteoarthritis Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Osteoarthritis Treatment Revenue by Countries (2015-2020)
Table 52. North America Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Osteoarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Osteoarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Osteoarthritis Treatment Revenue by Countries (2015-2020)
Table 56. South America Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Osteoarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Osteoarthritis Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Osteoarthritis Treatment Revenue Share by Type (2015-2020)
Table 61. Global Osteoarthritis Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Osteoarthritis Treatment Revenue by Application (2015-2020)
Table 63. Global Osteoarthritis Treatment Revenue Share by Application (2015-2020)
Table 64. Global Osteoarthritis Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Osteoarthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Osteoarthritis Treatment Picture
Figure 2. Global Osteoarthritis Treatment Revenue Market Share by Type in 2019
Figure 3. Drugs Picture
Figure 4. Assistive Devices Picture
Figure 5. Osteoarthritis Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Global Osteoarthritis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Osteoarthritis Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Osteoarthritis Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Osteoarthritis Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Osteoarthritis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Osteoarthritis Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Osteoarthritis Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Osteoarthritis Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Osteoarthritis Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Osteoarthritis Treatment Revenue Market Share by Countries in 2019
Figure 42. China Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Osteoarthritis Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Osteoarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Osteoarthritis Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Osteoarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Osteoarthritis Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Osteoarthritis Treatment Revenue Share by Type in 2019
Figure 59. Global Osteoarthritis Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Drugs Revenue Growth Rate (2015-2020)
Figure 61. Global Assistive Devices Revenue Growth Rate (2015-2020)
Figure 62. Global Osteoarthritis Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Osteoarthritis Treatment Revenue Share by Application in 2019
Figure 64. Global Osteoarthritis Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 66. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 67. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Osteoarthritis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Osteoarthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Osteoarthritis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Osteoarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
変形性関節症疼痛ソリューション の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …- 変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …
- 変形性股関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hip Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hip Osteoarthri…
- 変形性関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medicine for Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medicine fo…
- 脊椎変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Ost…